e-learning
resources
London 2016
Sunday, 04.09.2016
What's new in paediatric respiratory physiology?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Calculation of Scond between 0 and 3 lung turn over (Scond*) in mild to moderate chronic lung disease
Sylvia Nyilas (Basel, Switzerland), Sylvia Nyilas, Anja Bigler, Sophie Yammine, Cordula Koerner-Rettberg, Isabelle Rochat, Alexander Moeller, Gaudenz Hafen, Carmen Casaulta, Philipp Latzin, Florian Singer
Source:
International Congress 2016 – What's new in paediatric respiratory physiology?
Session:
What's new in paediatric respiratory physiology?
Session type:
Thematic Poster
Number:
1230
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sylvia Nyilas (Basel, Switzerland), Sylvia Nyilas, Anja Bigler, Sophie Yammine, Cordula Koerner-Rettberg, Isabelle Rochat, Alexander Moeller, Gaudenz Hafen, Carmen Casaulta, Philipp Latzin, Florian Singer. Calculation of Scond between 0 and 3 lung turn over (Scond*) in mild to moderate chronic lung disease. Eur Respir J 2016; 48: Suppl. 60, 1230
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
From pulmonary gas exchange to the interpretation of arterial blood gases
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Correlation between exercise capacity with FVC%, FEV1% and RV% in patients with airways diseases and severe and very severe lung function obstruction
Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2016
Annual FEV1 change : Post tuberculosis obstructive airway disease versus COPD
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013
Pulmonary function response in smokers and patients with chronic obstructive lung disease (COPD) following exposure to concentrated fine (PM
2.5
) particles
Source: Annual Congress 2009 - Indoor and outdoor air pollution
Year: 2009
Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT®
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012
Scond may better discriminate severe therapy resistant asthma (STRA) from mild-moderate asthma than lung clearance index (LCI)
Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease
Year: 2016
Measuring lung inhomogeneity in early chronic lung disease
Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2016
An increased respiratory drive accounts for the severity of dyspnea in systemic sclerosis
Source: Annual Congress 2013 –Respiratory muscles at rest and during exercise: from physiology to clinical context
Year: 2013
Lung function in school age children with chronic lung disease of prematurity
Source: International Congress 2015 – New findings in paediatric respiratory physiology
Year: 2015
Ventilation inhomogeneity in children with severe asthma and normal spirometry indicates residual airways disease
Source: Annual Congress 2013 –Clinical applications of respiratory physiology in children
Year: 2013
Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Effect of posture on lung clearance index (LCI) and lung volumes in children with early stage cystic fibrosis lung disease
Source: International Congress 2015 – Lung function: effects on method, machine and disease on the measurement
Year: 2015
Predictor parameters for exercise intolerance in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Lung volume response to bronchodilators is dependent on the stage of the disease in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2006 - COPD therapy
Year: 2006
Emphysematous lung sealant (ELS) therapy reduces CRP, an index of inflammation, in patients with severe emphysema (clinicaltrials.gov #NCT NCT00884962)
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Chronic obstructive pulmonary disease assessment test (CAT) in patients with COPD, chronic heart failure (CHF), and both
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept